Sabbagh MN - Search Results

1

Sensitivity to expectancy violations in healthy aging and mild cognitive impairment.

Davie JE, Azuma T, Goldinger SD, Connor DJ, Sabbagh MN, Silverberg NB. Davie JE, et al. Among authors: sabbagh mn. Neuropsychology. 2004 Apr;18(2):269-75. doi: 10.1037/0894-4105.18.2.269. Neuropsychology. 2004. PMID: 15099149

2

Progressive aphasia with Lewy bodies.

Caselli RJ, Beach TG, Sue LI, Connor DJ, Sabbagh MN. Caselli RJ, et al. Among authors: sabbagh mn. Dement Geriatr Cogn Disord. 2002;14(2):55-8. doi: 10.1159/000064925. Dement Geriatr Cogn Disord. 2002. PMID: 12145451

3

Should the guidelines for monitoring serum cholesterol levels in the elderly be re-evaluated?

Sparks DL, Connor DJ, Browne P, Sabbagh MN; AD Cholesterol-Lowering Treatment Trial Team. Sparks DL, et al. Among authors: sabbagh mn. J Mol Neurosci. 2002 Aug-Oct;19(1-2):209-12. doi: 10.1007/s12031-002-0035-1. J Mol Neurosci. 2002. PMID: 12212783

4

Length of stay in skilled nursing facilities is longer for patients with dementia.

Sabbagh MN, Silverberg N, Majeed B, Samant S, Sparks DL, Seward J, Connor DJ. Sabbagh MN, et al. J Alzheimers Dis. 2003 Feb;5(1):57-63. doi: 10.3233/jad-2003-5108. J Alzheimers Dis. 2003. PMID: 12590167

5

Abnormal corticomuscular coherence is associated with the small amplitude cortical myoclonus in Parkinson's disease.

Caviness JN, Adler CH, Sabbagh MN, Connor DJ, Hernandez JL, Lagerlund TD. Caviness JN, et al. Among authors: sabbagh mn. Mov Disord. 2003 Oct;18(10):1157-62. doi: 10.1002/mds.10525. Mov Disord. 2003. PMID: 14534920

6

Hippocampal adaptation to face repetition in healthy elderly and mild cognitive impairment.

Johnson SC, Baxter LC, Susskind-Wilder L, Connor DJ, Sabbagh MN, Caselli RJ. Johnson SC, et al. Among authors: sabbagh mn. Neuropsychologia. 2004;42(7):980-9. doi: 10.1016/j.neuropsychologia.2003.11.015. Neuropsychologia. 2004. PMID: 14998712

7

Case series of clinically probable dementia with Lewy bodies in two Native Americans.

Sabbagh MN, Silverberg NB, Walker D, Connor DJ, Seward JD, Crocker-Sabbagh IP, Descheny RL, Jim M, Baxter LC. Sabbagh MN, et al. Alzheimer Dis Assoc Disord. 2004 Oct-Dec;18(4):259-60. Alzheimer Dis Assoc Disord. 2004. PMID: 15592141

8

Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results.

Sparks DL, Sabbagh MN, Connor DJ, Lopez J, Launer LJ, Browne P, Wasser D, Johnson-Traver S, Lochhead J, Ziolwolski C. Sparks DL, et al. Among authors: sabbagh mn. Arch Neurol. 2005 May;62(5):753-7. doi: 10.1001/archneur.62.5.753. Arch Neurol. 2005. PMID: 15883262 Clinical Trial.

9

Atorvastatin therapy lowers circulating cholesterol but not free radical activity in advance of identifiable clinical benefit in the treatment of mild-to-moderate AD.

Sparks DL, Sabbagh MN, Connor DJ, Lopez J, Launer LJ, Petanceska S, Browne P, Wassar D, Johnson-Traver S, Lochhead J, Ziolkowski C. Sparks DL, et al. Among authors: sabbagh mn. Curr Alzheimer Res. 2005 Jul;2(3):343-53. doi: 10.2174/1567205054367900. Curr Alzheimer Res. 2005. PMID: 15974900 Clinical Trial.

10

Cholesterol, copper and Abeta in controls, MCI, AD and the AD cholesterol-lowering treatment trial (ADCLT).

Sparks DL, Petanceska S, Sabbagh M, Connor D, Soares H, Adler C, Lopez J, Ziolkowski C, Lochhead J, Browne P. Sparks DL, et al. Curr Alzheimer Res. 2005 Dec;2(5):527-39. doi: 10.2174/156720505774932296. Curr Alzheimer Res. 2005. PMID: 16375656 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

558 results

Search Page

Filters